Aung Naing

M D Anderson Cancer Center University of Texas - Houston / United States

Medical and Health Sciences / Immunology

AD Scientific Index ID: 1410572

MD Anderson Cancer Center

Registration, Add Profile,
Premium Membership

Print Your Certificate

Aung Naing's MOST POPULAR ARTICLES

1-) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice GuidelineJR Brahmer, C Lacchetti, BJ Schneider, MB Atkins, KJ Brassil, ...Journal of clinical oncology: official journal of the American Society of …, 201826772018

2-) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline updateBJ Schneider, J Naidoo, BD Santomasso, C Lacchetti, S Adkins, ...Journal of clinical oncology 39 (36), 4073-4126, 20215922021

3-) Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiativeAM Tsimberidou, NG Iskander, DS Hong, JJ Wheler, GS Falchook, S Fu, ...Clinical cancer research 18 (22), 6373-6383, 20125512012

4-) PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA MutationsF Janku, JJ Wheler, SN Westin, SL Moulder, A Naing, AM Tsimberidou, ...Journal of clinical oncology 30 (8), 777-782, 20125272012

5-) A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancerPA Ott, S Hu-Lieskovan, B Chmielowski, R Govindan, A Naing, ...Cell 183 (2), 347-362. e24, 20205172020

ARTICLES

Add your articles